Odo S, Tanabe K, Yohda M, Yamauchi M
Probiotics are known for altering the gut microbiome and may increase the production of short-chain fatty acids (SCFAs)
This has led to the creation of GLP-1 agonists and analogues capable of effectively activating all receptor and cellular systems compatible with GLP-1
Regarding coverage, if you have coverage for Wegovy (see above), you also probably have coverage for Zepbound
Older age, prior heart failure (HF) and CV events, peripheral artery disease, and kidney complications can identify a subgroup of patients with T2D at high risk of mortality who are likely to achieve the greatest benefit from aggressive management of modifiable risk factors and newer glucose-lowering agents
Before any protocol begins, the Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights spanning FTO, GLP1R, MC4R, and TCF7L2, turning a prescription into an informed conversation